NCT07625852

Brief Summary

Laparoscopic repair of Isthmocele aims to restore the anatomical integrity and physiological function of the lower uterine segment.

  • Vertical Closure: This technique involves closing the defect along the longitudinal axis of the uterus. Proponents suggest it may be more anatomically aligned with the muscle fibers of the lower uterine segment, potentially leading to stronger scar formation and reduced tension.
  • Transverse Closure: This technique involves closing the defect perpendicular to the long axis of the uterus. This approach is more commonly used during primary cesarean sections. Arguments for transverse closure in isthmocele repair include familiarity for surgeons and potentially less shortening of the lower uterine segment. However, the actual impact of these different closure methods on long-term outcomes such as defect recurrence, scar integrity, and fertility, remains largely unexplored in a randomized controlled trial setting.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
10mo left

Started Jun 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress17%
Jun 2026Jun 2027

First Submitted

Initial submission to the registry

May 29, 2026

Completed
3 days until next milestone

Study Start

First participant enrolled

June 1, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 4, 2026

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2027

Last Updated

June 4, 2026

Status Verified

May 1, 2026

Enrollment Period

1 year

First QC Date

May 29, 2026

Last Update Submit

May 29, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Postoperative lower uterine segment scar thickness

    To evaluate the thickness of the lower uterine segment scar at 6 and 12 months post-surgery using transvaginal ultrasound

    6 and 12 months post-surgery using transvaginal ultrasound

Study Arms (2)

Vertical Closure Group

ACTIVE COMPARATOR

The hysterotomy defect will be closed in two layers using interrupted or continuous sutures along the longitudinal axis of the uterus

Procedure: Vertical Closure

Transverse Closure Group

ACTIVE COMPARATOR

The hysterotomy defect will be closed in two layers using interrupted or continuous sutures perpendicular to the longitudinal axis of the uterus

Procedure: Transverse Closure

Interventions

The hysterotomy defect will be closed in two layers using interrupted or continuous sutures along the longitudinal axis of the uterus

Vertical Closure Group

The hysterotomy defect will be closed in two layers using interrupted or continuous sutures perpendicular to the longitudinal axis of the uterus

Transverse Closure Group

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Women aged 18-45 years.
  • Diagnosis of symptomatic isthmocele confirmed by transvaginal ultrasound (myometrial thickness at the defect \< 2.5 mm).
  • History of at least one prior cesarean section.
  • Symptoms attributable to isthmocele (e.g., abnormal uterine bleeding, pelvic pain, dysmenorrhea, secondary infertility).
  • Desire for surgical correction of isthmocele.
  • Ability to understand and provide informed consent

You may not qualify if:

  • Asymptomatic isthmocele.
  • Active pelvic infection or malignancy.
  • Significant medical comorbidities contraindicating laparoscopic surgery.
  • Coagulopathy.
  • Known uterine anomalies (e.g., bicornuate uterus).
  • Pregnancy at the time of recruitment.
  • Inability to comply with follow-up protocol.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of Obstetrics and Gynecology

Study Record Dates

First Submitted

May 29, 2026

First Posted

June 4, 2026

Study Start

June 1, 2026

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

June 1, 2027

Last Updated

June 4, 2026

Record last verified: 2026-05